Skip to main content
Premium Trial:

Request an Annual Quote

Pierre Chretien, Michael Berens, Robert Penny, Michael Bittner, Michael Rodgers, Thomas Klopack, Joseph Limber, Ed Hurwitz

Premium

Pierre Chretien of Montreal was named director of Canada marketing and business development for the company Pure Protein. Previously, Chretien was chief technical officer for SignalGene.

 

Michael Berens, a researcher at Arizona’s Translational Genomics Research Institute, has become CEO of the International Genomics Consortium, according to an IGC announcement. Berens, a former researcher at the Barrow Neurological Institute, will keep his position as senior investigator at the Translational Genomics Research Institute in order to be able to pursue federally funded research. Further, the Phoenix, Ariz.-based consortium named Robert Penny as chief medical officer, Michael Bittner as chief research officer, and Michael Rodgers as chief financial officer. In addition, Max Poll, president and CEO at Scottsdale Healthcare, was elected to the IGC’s board.

 

Aclara Biosciences has appointed Thomas Klopack as CEO. Klopack was COO of Aurora Biosciences from 1998 until 2002. He fills an opening created when CEO Joseph Limber left last December, and Ed Hurwitz, a board member who was appointed interim CEO at the time, then stepped down Feb. 21. Klopack holds an MBA from Harvard Business School and a BS in engineering from Carnegie-Mellon University.

 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.